相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma
Michelle L. Gervais et al.
LABORATORY INVESTIGATION (2007)
Dominant-negative HIF-3α4 suppresses VHL-null renal cell carcinoma progression
Mindy A. Maynard et al.
CELL CYCLE (2007)
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2
Haifeng Yang et al.
MOLECULAR CELL (2007)
Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease
Kirsten Brukamp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Essential role for prolyl hydroxylase domain protein 2 in oxygen Homeostasis of the adult vascular system
Kotaro Takeda et al.
CIRCULATION (2007)
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Carole Peyssonnaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of primary cilia in the pathogenesis of polycystic kidney disease
Bradley K. Yoder
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
pVHL and GSK3β are components of a primary cilium-maintenance signalling network
Claudio R. Thoma et al.
NATURE CELL BIOLOGY (2007)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
Erinn B. Rankin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Targeted inactivation of Fh1 causes proliferative renal cyst development and activation of the hypoxia pathway
Patrick J. Pollard et al.
CANCER CELL (2007)
Acute postnatal ablation of Hif-2α results in anemia
Michaela Gruber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The hypoxia-inducible factor a pathway couples angiogenesis to osteogenesis during skeletal development
Ying Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail
Andrew J. Evans et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth
Bernhard Schermer et al.
JOURNAL OF CELL BIOLOGY (2006)
Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2
Kotaro Takeda et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo
William Y. Kim et al.
EMBO JOURNAL (2006)
The !von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells
Benedetta Peruzzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice
Mei Ding et al.
NATURE MEDICINE (2006)
Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells
Mallory S. Lutz et al.
CANCER RESEARCH (2006)
Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis
Seung-Beom Hong et al.
LABORATORY INVESTIGATION (2006)
Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein
Miguel A. Esteban et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
p53 stabilization and transactivation by a von Hippel-Lindau protein
Jae-Seok Roe et al.
MOLECULAR CELL (2006)
Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in stem cells
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
pVHL function is essential for endothelial extracellular matrix deposition
N Tang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor
MA Esteban et al.
CANCER RESEARCH (2006)
Rend cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor
EB Rankin et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B
B Krishnamachary et al.
CANCER RESEARCH (2006)
von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms
MJ Calzada et al.
CANCER RESEARCH (2006)
Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis
G Kurban et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Hypoxia inducible factor 1α regulates T cell receptor signal transduction
AK Neumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hypoxia requires Notch signaling to maintain the undifferentiated cell state
MV Gustafsson et al.
DEVELOPMENTAL CELL (2005)
Genetic evidence for a tumor suppressor role of HIF-2α
T Acker et al.
CANCER CELL (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer
K Smith et al.
CANCER RESEARCH (2005)
Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice
EB Rankin et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene
CC Wykoff et al.
BRITISH JOURNAL OF CANCER (2004)
Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice
E Kleymenova et al.
CARCINOGENESIS (2004)
Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent
MI Zhou et al.
CANCER RESEARCH (2004)
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis
J Karhausen et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor
RJ Appelhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations
WK Rathmell et al.
CANCER RESEARCH (2004)
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (HIF) in regulating HIF transcriptional target genes
IP Stolze et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes
MP Biju et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans
T Bishop et al.
PLOS BIOLOGY (2004)
HIF-1α induces cell cycle arrest by functionally counteracting Myc
M Koshiji et al.
EMBO JOURNAL (2004)
Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development
D Pfander et al.
DEVELOPMENT (2004)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
P Staller et al.
NATURE (2003)
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia
E Berra et al.
EMBO JOURNAL (2003)
The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1α transcriptional activity
ZB Li et al.
EMBO JOURNAL (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 uhiquitin ligase complex
MA Maynard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HIF-1α is essential for myeloid cell-mediated inflammation
T Cramer et al.
CELL (2003)
von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination
AV Kuznetsova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth
FA Mack et al.
CANCER CELL (2003)
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
A Hergovich et al.
NATURE CELL BIOLOGY (2003)
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
SO Ang et al.
NATURE GENETICS (2002)
The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1
MI Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of hypoxia-inducible factor-1α and -2α in hypoxic and ischemic rat kidneys
C Rosenberger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Structural basis for the recognition of hydroxyproline in αIF-1α by pVHL
WC Hon et al.
NATURE (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
JK Maranchie et al.
CANCER CELL (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein
ZB Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
D Lando et al.
SCIENCE (2002)
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C
H Okuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
The von Hhippel-Lindau protein interacts with heteronuclear ribonucleoprotein A2 and regulates its expression
PA Pioli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation
N Masson et al.
EMBO JOURNAL (2001)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
MA Hoffman et al.
HUMAN MOLECULAR GENETICS (2001)
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford et al.
HUMAN MOLECULAR GENETICS (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor
VH Haase et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling
EJ Davidowitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
T Kamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mechanism of regulation of the hypoxia-inducible factor-lα by the von Hippel-Lindau tumor suppressor protein
K Tanimoto et al.
EMBO JOURNAL (2000)
Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer
K Datta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
分享论文
